Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Transanal Endoscopic Intersphincteric Resection (taE-ISR) in Extreme Anal Preservation in Ultra-low Rectal Cancer

NCT05933785 is registered in ClinicalTrials.gov with Shanghai Minimally Invasive Surgery Center as lead sponsor.

NCT NCT05933785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05933785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Transanal Endoscopic Intersphincteric Resection (taE-ISR) in Extreme Anal Preservation in Ultra-low Rectal Cancer
Lead sponsor
Shanghai Minimally Invasive Surgery Center
Phase
Observational
Overall status
Completed
Start date
January 2, 2018
Completion date
May 30, 2023
Enrollment
260 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer